• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Incyte Corporation (INCY)

    -NasdaqGS
    88.68 Up 2.83(3.30%) 4:00PM EST
    |After Hours : 89.25 Up 0.57 (0.64%) 5:43PM EST
    Add to Portfolio
    Prev Close:85.85
    Open:85.48
    Bid:88.60 x 200
    Ask:89.87 x 100
    1y Target Est:91.08
    Beta:0.16
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:85.19 - 88.93
    52wk Range:40.30 - 88.93
    Volume:932,469
    Avg Vol (3m):1,157,150
    Market Cap:15.23B
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 3.30%15.23B
    AMGNUp 1.21%121.14B
    CELGDown 1.00%96.32B
    RHHBYDown 0.42%N/A

    Key Statistics

    Forward P/E (1 yr):87.80
    P/S (ttm):28.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.25
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-4.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback